Smithfield Trust’s ArcBest ARCB Stock Holding History

Smithfield Trust’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-105	Closed	-$6K	–	1054
2022 Q2	$6K	Hold	105	–	–	﹤0.01%	912
2022 Q1	$9K	Sell	105 -2	-2%	-$180	﹤0.01%	848
2021 Q4	$12K	Hold	107	–	–	﹤0.01%	807
2021 Q3	$8K	Buy	+107	New	+$7.05K	﹤0.01%	888

Other funds holding ARCB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Smithfield Trust's ARCB Position: Q3 2022 in Review

Smithfield Trust sold out of ArcBest (ARCB) in Q3 2022, closing a stake of 105 shares — an estimated $6K sold.

Smithfield Trust first reported a position in ARCB in Q3 2021 and held it in 4 quarters. The position peaked at $12K in Q4 2021. 258 funds tracked by Wall St. Rank hold ARCB as of Q3 2022.

Smithfield Trust reported no remaining ArcBest position as of Q3 2022 after selling out during the quarter.
Smithfield Trust sold 105 ArcBest shares in Q3 2022, an estimated $6K.
Smithfield Trust first reported a position in ArcBest in Q3 2021 and held it in 4 quarters.
Smithfield Trust's ArcBest position peaked at $12K in Q4 2021.
258 funds tracked by Wall St. Rank held ArcBest as of Q3 2022.

Based on Smithfield Trust's 13F filing for Q3 2022, filed 14 Nov 2022.